{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.46 vs. cons $0.41",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.85bn vs. cons $1.79bn",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Free cash flow attributable to EQT",
      "prediction": "MISS",
      "answer": "pred ~$250m vs. cons $275m",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Full-year 2026 total sales volume",
      "prediction": "UNCHANGED",
      "answer": "guide ~2,325 Bcfe vs. cons 2,325 Bcfe (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Full-year 2026 total capital expenditures",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.75bn vs. cons $2.75bn (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Full-year 2026 operating costs",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.14/Mcfe vs. cons $1.14/Mcfe (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Year-end net debt target",
      "prediction": "UNCHANGED",
      "answer": "guide ~$5.0bn vs. cons $5.1bn (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "EPS and revenue beat estimates by ~$0.05/share and ~$0.06bn, respectively, but predicted FCF of ~$250m versus ~$275m consensus and an unchanged ~$2.75bn FY2026 capital plan leave out-period cash-flow math softer; revisions should drift lower after the initial reaction.",
  "day5_confidence": "MEDIUM"
}